★ Topic
Drug Pricing Policy
$27B documented · May 2025 – November 2025
- Actions
- 2
- People
- 1
- Orgs
- 1
- Sectors
- 13
Trump has used executive power and direct negotiations with pharmaceutical manufacturers to reshape drug pricing, delivering politically visible price cuts while binding companies to broad MFN commitments in exchange for favorable regulatory and market access conditions.
Actions
People
Ranked by appearances across this topic's actions.
Organizations
Ranked by appearances across this topic's actions.
Sectors involved
Derived from the organizations and individuals involved.